Download PDF
Synlett 2007(20): 3183-3187  
DOI: 10.1055/s-2007-992373
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Oxazinyl Analogues of Fosmidomycin Using RCM Methodology

Sarah Van der Jeught, Christian V. Stevens*, Nicolai Dieltiens
Research Group SynBioC, Department of Organic Chemistry, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium
Fax: +32(9)2646243; e-Mail: Chris.Stevens@ugent.be;
Further Information

Publication History

Received 20 September 2007
Publication Date:
21 November 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

Fosmidomycin is a promising antimalarial compound with a novel mode of action, the inhibition of 1-deoxy-d-xylulose 5-phosphate reductoisomerase, a key enzyme in the biosynthesis of isoprenoids through the nonmevalonate pathway. This paper describes the synthesis of a series of analogues in which the hydroxamate moiety is incorporated in a ring structure, leaving the complexation with the enzyme up to the oxygen lone pairs instead of the free hydroxyl group. The antimalarial activities of the different analogues are currently under investigation.

Key words

fosmidomycin - oxazinyl analogues - 1-deoxy-d-xylulose 5-phosphate reductoisomerase - ring-closing metathesis - heterogeneous ruthenium catalysis

    References and notes

  • 2 Thayer A. Chem. Eng. News  2005,  83 (October 24):  69 
    Google Scholar
  • 3 Missinou M. Borrmann S. Schindler A. Issifou S. Adegnika A. Matsiegui P. Binder R. Lell B. Wiesner J. Baranek T. Jomaa H. Kremsner P. Lancet  2002,  360:  1941 
    CrossrefGoogle Scholar
  • 4 Lell B. Ruangweerayut R. Wiesner J. Missinou M. Schindler A. Baranek T. Hintz M. Hutchinson D. Jomaa H. Kremsner P. Antimicrob. Agents Chemother.  2003,  47:  735 
    CrossrefGoogle Scholar
  • 5 Wiesner J. Ortmann R. Jomaa H. Schlitzer M. Angew. Chem. Int. Ed.  2003,  42:  5274 
    CrossrefGoogle Scholar
  • 6 Tsuchiya T. Ishibashi K. Terakawa M. Nishiyama M. Itoh N. Noguchi H. Eur. J. Drug. Metab. Pharmacokinet.  1982,  7:  59 
    Google Scholar
  • 7a Kuemmerle HP. Murakawa T. De Santis F. Chemioterapia  1987,  6:  113 
    Google Scholar
  • 7b Kuemmerle HP. Murakawa T. Sakamoto H. Sato N. Konishi T. De Santis F. Int. J. Clin. Pharmacol. Ther. Toxicol.  1985,  23:  521 
    Google Scholar
  • 8 Reuter K. Sanderbrand S. Jomaa H. Wiesner J. Steinbrecher I. Beck E. Hintz M. Klebe G. Stubbs MT. J. Biol. Chem.  2002,  277:  5378 
    CrossrefGoogle Scholar
  • 9 Reichenberg A. Wiesner J. Weidemeyer C. Dreiseidler E. Sanderbrand S. Altincicek B. Beck E. Schlitzer M. Jomaa H. Bioorg. Med. Chem. Lett.  2001,  11:  833 
    CrossrefGoogle Scholar
  • 10a Ortmann R. Wiesner J. Reichenberg A. Henschker D. Beck E. Jomaa H. Schlitzer M. Arch. Pharm. Chem. Life Sci.  2005,  338:  305 
    CrossrefGoogle Scholar
  • 10b Ortmann R. Wiesner J. Reichenberg A. Henschker D. Beck E. Jomaa H. Schlitzer M. Bioorg. Med. Chem. Lett.  2003,  13:  2163 
    CrossrefGoogle Scholar
  • 11 Kurz T. Schlüter K. Kaula U. Bergmann B. Walter RD. Geffken D. Bioorg. Med. Chem.  2006,  14:  5121 
    CrossrefGoogle Scholar
  • 12 Kurz T. Geffken D. Wackendorff C. Z. Naturforsch., B  2003,  58b:  457 
    Google Scholar
  • 13 Woo YH. Fernandes RPM. Proteau PJ. Bioorg. Med. Chem.  2006,  14:  2375 
    CrossrefGoogle Scholar
  • 14 Courtois M. Mincheva Z. Andreu F. Rideau M. Viaud-Massuard M. J. Enz. Inh. Med. Chem.  2004,  19:  559 
    Google Scholar
  • 15 Mincheva Z. Courtois M. Andreu F. Rideau M. Viaud-Massuard MC. Phytochemistry  2005,  66:  1797 
    CrossrefGoogle Scholar
  • 16 Kuntz L. Tritsch D. Grosdemange-Billiard C. Hemmerlin A. Willem A. Bacht TJ. Rohmer M. Biochem. J.  2005,  386:  127 
    CrossrefGoogle Scholar
  • 17 Devreux V. Wiesner J. Goeman JL. Van der Eycken J. Jomaa H. Van Calenbergh S. J. Med. Chem.  2006,  49:  2656 
    CrossrefPubMedGoogle Scholar
  • 18 Kurz T. Schlüter K. Pein M. Behrendt C. Bergmann B. Walter RD. Arch. Pharm. Chem. Life Sci.  2007,  340:  339 
    CrossrefGoogle Scholar
  • 19 Haemers T. Wiesner J. Busson R. Jomaa H. Van Calenbergh S. Eur. J. Org. Chem.  2006,  3856 
    CrossrefGoogle Scholar
  • 20a Haemers T. Wiesner J. Van Poecke S. Goeman J. Henschker D. Beck E. Jomaa H. Van Calenbergh S. Bioorg. Med. Chem. Lett.  2006,  16:  1888 
    CrossrefGoogle Scholar
  • 20b Devreux V. Wiesner J. Jomaa H. Rozenski J. Van der Eycken J. Van Calenbergh S. J. Org. Chem.  2007,  72:  3783 
    CrossrefGoogle Scholar
  • 21a Yang Y.-K. Tae J. Synlett  2003,  1043 
    CrossrefGoogle Scholar
  • 21b Miyabe H. Yoshida K. Matsumura A. Yamauchi M. Takemoto Y. Synlett  2003,  567 
    CrossrefGoogle Scholar
  • 21c Koide K. Finkelstein JM. Ball Z. Verdine GL. J. Am. Chem. Soc.  2001,  123:  398 
    CrossrefGoogle Scholar
  • 21d Le Flohic A. Meyer C. Cossy J. Desmurs JR. Tetrahedron Lett.  2003,  44:  8577 
    CrossrefGoogle Scholar
  • 21e Shustov GV. Chandler MK. Wolfe S. Can. J. Chem.  2005,  83:  93 
    CrossrefGoogle Scholar
  • 22 Van Meenen E. Moonen K. Verwee A. Stevens CV.
    J. Org. Chem.  2006,  71:  7903 
    Google Scholar
  • 23 Teulade M. Savignac P. Synthesis  1987,  1037 
    Article in Thieme ConnectGoogle Scholar
  • 24 Albrecht S. Defoin A. Tarnus C. Synthesis  2006,  1635 
    Article in Thieme ConnectGoogle Scholar
  • 25 Eguchi S. Furukawa Y. Suzuki T. Kondo K. Sasaki T. Honda M. Katayama C. Tanaka J. J. Org. Chem.  1985,  50:  1895 
    CrossrefGoogle Scholar
  • 27 For a summary of existing methods for removal of Ru species, see: Conrad JC. Fogg DE. Curr. Org. Chem.  2006,  10:  185 
    CrossrefGoogle Scholar
  • 28a Maynard HD. Grubbs RH. Tetrahedron Lett.  1999,  40:  4137 
    CrossrefGoogle Scholar
  • 28b Grubbs RH. Org. React. (N.Y.)  2004,  22:  123 
    CrossrefGoogle Scholar
  • 28c Ahn YM. Yang K. Georg GI. Org. Lett.  2001,  3:  1411 
    CrossrefGoogle Scholar
  • 28d Paquette LA. Schloss JD. Efremov I. Fabris F. Gallou F. Mendez-Andino J. Yang J. Org. Lett.  2000,  2:  1259 
    CrossrefGoogle Scholar
  • 28e McEleney K. Allen DP. Holliday AE. Crudden CM. Org. Lett.  2006,  8:  2663 
    CrossrefGoogle Scholar
  • 28f Galan BR. Kalbarczyk KP. Szczepankiewicz S. Keister JB. Diver ST. Org. Lett.  2007,  9:  1203 
    CrossrefGoogle Scholar
  • 28g Cho JH. Kim BM. Org. Lett.  2003,  5:  531 
    CrossrefGoogle Scholar
1

Aspirant of the Fund for Scientific Research, Flanders (FWO, Vlaanderen), Belgium.

26

Preparation of Diethyl 1-Phenyl-3-(4-methyl-3-oxo-3,6-dihydro-2 H -1,2-oxazin-2-yl)propylphosphonate (10b): A solution of 9b (1 g, 2.53 mmol) in anhyd CH2Cl2 (30 mL) was brought under a N2 atmosphere. The mixture was stirred at reflux temperature and Grubbs’ second-generation catalyst (0.1073 g, 0.126 mmol) was added. After 6 h of refluxing, the solvents were evaporated under vacuum to yield the product 10b as a crude oil. Purification by column chromatography was necessary to remove the traces of the ruthenium catalyst, yielding 10b (0.70 g, 1.90 mmol, 75%). 1H NMR (300 MHz, CDCl3): δ = 1.08 (t, J = 7.0 Hz, 3 H, OEt), 1.29 (t, J = 7.0 Hz, 3 H, OEt), 1.88 (q, J = 1.7 Hz, 3 H, CMe), 2.22-2.35 (m, 1 H, CHAHBCHP), 2.40-2.54 (m, 1 H, CHAHBCHP), 3.11 (ddd, J = 3.1, 11.2, 23.1 Hz, 1 H, CHP), 3.46 (ddd, J = 6.7, 6.8, 14.0 Hz, 1 H, CHAHBN), 3.59 (ddd, J = 7.2, 7.2, 14.0 Hz, 1 H, CHAHBN), 3.66-4.11 (m, 4 H, 2 × OEt), 4.35 (ddq, J = 1.7, 3.5, 15.4 Hz, 1 H, OCHAHBCH=C), 4.44 (ddq, J = 1.7, 3.5, 15.4 Hz, 1 H, OCHAHBCH=C), 6.35 (tq, J = 1.7, 3.5 Hz, 1 H, OCH2CH=C), 7.23-7.37 (m, 5 H, CHarom). 13C NMR (75 MHz, CDCl3, ref. CDCl3): δ = 15.70 (CMe), 16.27, 16.35, 16.45, 16.54 (2 × OEt), 27.78 (J C-P = 2.3 Hz, CH2CHP), 42.33 (J C-P = 138.5 Hz, CHP), 45.14 (J C-P = 18.5 Hz, CH2N), 61.97 (J C-P = 6.9 Hz, OEt), 62.81 (J C-P = 6.9 Hz, OEt), 67.54 (OCH2CH=C), 77.13 (CDCl3), 127.44 (J C-P = 2.3 Hz, CHarom), 128.67 (J C-P = 2.3 Hz, 2 × CHarom), 129.40 (J C-P = 6.9 Hz, 2 × CHarom), 129.67 (CMe), 132.92 (OCH2CH=C), 135.48 (J C-P = 6.9 Hz, Cq,arom), 166.46 (CO). 31P NMR (109 MHz, CDCl3): δ = 28.92. IR (NaCl): 1674, 1635 (C=O, C=C), 1242 (P=O), 1058, 1028 (PO) cm-1. MS (ESI, +ve mode, %): m/z = 368.3 (100) [M + H+]. Chromatography (PE-EtOAc, 1:4): R f = 0.18.

29

Preparation of Diammonium 1-Phenyl-3-(4-methyl-3-oxo-3,6-dihydro-2 H -1,2-oxazin-2-yl)propylphos-phonate (1b): To a solution of 10b (0.50 g, 1.36 mmol) in anhyd MeCN at r.t. was added dropwise TMSBr (13.6 mmol) and this mixture was stirred at r.t. for 24 h. The solvents and traces of TMSBr were removed under reduced pressure and under high vacuum. The residual oil was dissolved in H2O and the pH was adjusted with a 5% NH4OH solution to pH 8-9. Lyophilization of the solution resulted in a solid and purification was performed by column chromatography on Whatman CF11 cellulose. The solvent used was MeCN-aq 1 M NH4OH (5:1) and the fractions were analyzed on cellulose TLC with the use of UV light to visualize the spots after dipping the plates in a pinacryptol yellow solution (0.1% in H2O) and drying with hot air. The desired fractions were again lyophilized, yielding 1b as a pale brown hygroscopic solid (0.31 g, 0.88 mmol, 65%). 1H NMR (300 MHz, CDCl3): δ = 1.72 (d, J = 1.7 Hz, 3 H, CMe), 2.14-2.42 (m, 2 H, CH2CHP), 2.93 (ddd, J = 3.0, 11.8, 22.0 Hz, 1 H, CHP), 3.50 (t, J = 6.5 Hz, 2 H, CH2N), 4.31 (ddd, J = 1.9, 3.6, 15.7 Hz, 1 H, OCHAHBCH=C), 4.44 (ddq, J = 1.9, 3.4, 15.7 Hz, 1 H, OCHAHBCH=C), 4.79 (D2O), 6.45 (tq, J = 1.7, 1.7 Hz, 1 H, OCH2CH=C), 7.19-7.35 (m, 5 H, 5 × CHarom). 13C NMR (75 MHz, CDCl3, ref. MeCN): δ = 1.47 (ref. MeCN), 15.20 (CMe), 28.13 (J C-P = 2.3 Hz, CH2CHP), 44.79 (J C-P = 129.2 Hz, CHP), 45.94 (J C-P = 17.3 Hz, CH2N), 68.24 (OCH2CH=C), 119.69 (ref. MeCN), 127.17 (J C-P = 2.3 Hz, CHarom), 128.36 (CMe), 129.00 (J C-P = 2.3 Hz, 2 × CHarom), 129.69 (J C-P = 6.9 Hz, 2 × CHarom), 135.26 (OCH2CH=C), 139.14 (J C-P = 6.9 Hz, Cq,arom), 166.73 (CO). 31P NMR (109 MHz, CDCl3): δ = 22.91. IR (NaCl): 1668 (C=O, C=C), 1033 (PO) cm-1. MS (ESI, -ve mode, %): m/z = 310.3 (100) [M - +NH4 - NH3]. Chromatography (MeCN-1 M NH4OH, 5:1): R f = 0.16.